Investing Profile

Elena Viboch

InvestorVC
Managing Director at General Catalyst
generalcatalyst.comSan Francisco Bay Area
Photo of Elena Viboch, Managing Director at General Catalyst
Your Intro Paths to Elena Viboch

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Elena Viboch's investing connections

Connected to 2 investors on Signal.

Sign in with Google →
Networks Elena is a member of
NewCo Network
1611 CONNECTIONS
NewCo Network
1611 CONNECTIONS
Top-Patents Network
1038 CONNECTIONS
Top-Patents Network
1038 CONNECTIONS
BlueStone Capital Partners, L.P. Network
553 CONNECTIONS

Find Elena Viboch on

cb
Current Investing Position
General Catalyst Managing Director
Investment Range
$500K - $2.0M
Sweet Spot
$500K
Investments On Record
30
Current Fund Size
$1.1B

Elena Viboch is on these Sector & Stage Rankings

Elena Viboch's Investments On Record (21)

CompanyStageDateRound SizeTotal Raised
Faro AI
Series BAug 2026$37M
Series AFeb 2023$20M
$72M
Co-investors: Andy Harrison (Section 32)
Chai Discovery
Series CJul 2026$400M
Series BDec 2025$130M
$630M
Co-investors: Nina Achadjian (Index Ventures), Hemant Taneja (General Catalyst), Patrick Grady (Sequoia Capital), Fred Ehrsam (Paradigm), Greg Yap (Menlo Ventures), Lachy Groom (Physical Intelligence), Annie Lamont (Oak HC/FT), Ilya Fushman (Kleiner Perkins), Zavain Dar (Dimension Capital), Nitesh Banta (Getaround)
Parabilis Medicines
Series FJan 2026$310M
Series EMar 2024$150M
$800M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Corey Goodman (venBio Partners), Thilo Schroeder (Nextech Invest), Jake Simson (RA Capital Management)
Paradigm
Series BDec 2025$78M
Series AJan 2023$200M
$320M
Co-investors: David Schenkein (GV (Google Ventures)), Balaji Srinivasan (Andreessen Horowitz), Hemant Taneja (General Catalyst), Niko Bonatsos (General Catalyst), Max Rimpel (General Catalyst), Bilal Zuberi (Lux Capital), Ramnik Arora (Original Capital), Arash Ferdowsi (Dropbox), Eoghan McCabe (Spark-Local, Inc), Brett Cook (F-Prime Capital (formerly Fidelity Biosciences)), Jay Markowitz (ARCH Venture Partners), Stephen Knight (F-Prime Capital (formerly Fidelity Biosciences)), Robert Nelsen (ARCH Venture Partners), Alaa Halawa (Mubadala), Justin Kao (DFJ Growth), Jared Friedman (Y Combinator), Scott Belsky (A24), Karim Atiyeh
Tahoe Therapeutics
Series AAug 2025$30M
SeedDec 2022$12M
$42M
Co-investors: Deep Nishar (General Catalyst), Gaurav Garg (Wing Venture Capital), Krish Ramadurai (AIX Ventures), Sunil Dhaliwal (Amplify Partners), Ayman AlAbdallah
Maxion Therapeutics
Series AMar 2025$75M
$91M
Co-investors: Lucy Edwardes-Jones (BGF Ventures)
Eikon Therapeutics
Series DFeb 2025$350M
Series BJan 2022$520M
$1B
Co-investors: Josh Wolfe (Lux Capital), Adam Goulburn (6 Dimensions Capital), Larry Lasky (The Column Group), Leon Chen (The Column Group), Eric Schmidt (Innovation Endeavors), Dror Berman (Innovation Endeavors)
Manas AI
SeedJan 2025$25M
$25M
Co-investors: Hemant Taneja (General Catalyst), Reid Hoffman (Greylock)

Elena Viboch's Experience

Managing Director General Catalyst2024 - Present
Senior Manager, Corporate Development & Strategy MILCOM TechnologiesPresent
Director of Business Development & Operations MILCOM TechnologiesPresent
Senior Manager, Corporate Development & Strategy Still Water DesignPresent
Director of Business Development & Operations Still Water DesignPresent
Senior Manager, Corporate Development & Strategy BlueStone Capital Partners, L.P.Present
Director of Business Development & Operations BlueStone Capital Partners, L.P.Present
Director of Business Development & Operations FLX Bio, Inc.Present
Consultant PutnamPresent
Senior Manager, Corporate Development & Strategy Top-PatentsPresent
Director of Business Development & Operations Top-PatentsPresent
Partner General Catalyst PartnersPresent
Managing Director General Catalyst PartnersPresent
Senior Manager, Corporate Development & Strategy NewCoPresent
Director of Business Development & Operations NewCoPresent
Partner General Catalyst2022 - 2024
Investment Director SoftBank Investment Advisers2019 - 2022
Director of Corporate Development NanoString Technologies, Inc.2017 - 2019
Director of Business Development & Operations Carmot Therapeutics2016 - 2017
Senior Manager, Corporate Development & Strategy FLX Bio, Inc.2015 - 2016
Corporate Development Jazz Pharmaceuticals2014 - 2014
Investor Kearny Venture Partners2011 - 2014
Consultant Putnam Associates2009 - 2011

Elena Viboch's Education

The Johns Hopkins University Master of Science - MS Biotechnology

Investors who invest with Elena Viboch

Sign in with Google →

Scouts & Angels Affiliated With Elena Viboch

Sign in with Google →